MDXG — MiMedx Group Inc · P/E 18, rev $123.4M

MiMedx Group Inc (MDXG) is a biotechnology company listed on US.

Latest reported MDXG revenue for 2026-06-30 was $123.4M. Net income was -$25.7M. MDXG currently screens at market cap $537.7M and trailing P/E 18.1.

Use this MDXG page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MDXG quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MDXG SEC filings page. Lician reads the product cache first so this HTML stays unique to MiMedx Group Inc even when a live quote feed is slow.

MiMedx Group Inc latest statements (FY2025)

Latest cached year on this hub. Full MDXG income, balance, and cash tables.

  • Revenue$418.6M
  • Net Income$48.6M
  • Total Assets$342.7M
  • Total Debt$0
  • Free Cash Flow$0

MDXG recent filings